You are here

Article info

Article menu
Download PDFPDF
Drug therapy
Review
Azithromycin, Ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development

Authors

  1. Correspondence to Sailesh Kotecha, Department of Child Health, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; KotechaS{at}cardiff.ac.uk
View Full Text

Citation

Turner MA, Jacqz-Aigrain E, Kotecha S
Azithromycin, Ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development
Archives of Disease in Childhood 2012;97:573-577.

Publication history

  • Accepted May 23, 2011
  • First published June 22, 2011.
Online issue publication 
December 13, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions